These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 27095332)

  • 21. A prospective 12-week study of quetiapine in adolescents with schizophrenia spectrum disorders.
    Schimmelmann BG; Mehler-Wex C; Lambert M; Schulze-zur-Wiesch C; Koch E; Flechtner HH; Gierow B; Maier J; Meyer E; Schulte-Markwort M
    J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):768-78. PubMed ID: 18315449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study.
    Wang X; Savage R; Borisov A; Rosenberg J; Woolwine B; Tucker M; May R; Feldman J; Nemeroff CB; Miller AH
    J Psychiatr Res; 2006 Oct; 40(7):669-76. PubMed ID: 16762371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the use of the positive and negative syndrome scale-excited component as a criterion for administration of p.r.n. medication.
    Chaichan W
    J Psychiatr Pract; 2008 Mar; 14(2):105-13. PubMed ID: 18360196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sleep propensity at daytime as assessed by Multiple Sleep Latency Tests (MSLT) in patients with schizophrenia increases with clozapine and olanzapine.
    Kluge M; Himmerich H; Wehmeier PM; Rummel-Kluge C; Dalal M; Hinze-Selch D; Kraus T; Dittmann RW; Pollmächer T; Schuld A
    Schizophr Res; 2012 Mar; 135(1-3):123-7. PubMed ID: 22257975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.
    Krakowski MI; Czobor P; Citrome L; Bark N; Cooper TB
    Arch Gen Psychiatry; 2006 Jun; 63(6):622-9. PubMed ID: 16754835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fasting insulin serum levels and psychopathology profiles in male schizophrenic inpatients treated with olanzapine or risperidone.
    Konarzewska B; Waszkiewicz N; Galińska B; Szulc A
    Neuro Endocrinol Lett; 2013; 34(4):322-8. PubMed ID: 23803867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sleep Misperception and Associated Factors in Patients With Anxiety-Related Disorders and Complaint of Insomnia: A Retrospective Study.
    Liang Y; Zhao X; Zhang C; Liu G; Lu B; Han L; Tong F; Luo X; Hu C; Liu H
    Front Neurol; 2022; 13():836949. PubMed ID: 35463154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationships between positive or negative early subjective response to antipsychotics and demographic and clinical variables in the group of patients with schizophrenia].
    Murawiec S
    Psychiatr Pol; 2005; 39(6):1185-98. PubMed ID: 16526184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initial severity of schizophrenia and efficacy of antipsychotics: participant-level meta-analysis of 6 placebo-controlled studies.
    Furukawa TA; Levine SZ; Tanaka S; Goldberg Y; Samara M; Davis JM; Cipriani A; Leucht S
    JAMA Psychiatry; 2015 Jan; 72(1):14-21. PubMed ID: 25372935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia.
    Fan X; Pristach C; Liu EY; Freudenreich O; Henderson DC; Goff DC
    Psychiatry Res; 2007 Jan; 149(1-3):267-71. PubMed ID: 17112596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative study on quality of life of patients of schizophrenia with and without depression.
    Dan A; Kumar S; Avasthi A; Grover S
    Psychiatry Res; 2011 Sep; 189(2):185-9. PubMed ID: 21453977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sleep EEG characteristics associated with sleep onset misperception.
    Hermans LWA; Leufkens TR; van Gilst MM; Weysen T; Ross M; Anderer P; Overeem S; Vermeeren A
    Sleep Med; 2019 May; 57():70-79. PubMed ID: 30897458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolactin, subjective well-being and sexual dysfunction: an open label observational study comparing quetiapine with risperidone.
    Westheide J; Cvetanovska G; Albrecht C; Bliesener N; Cooper-Mahkorn D; Creutz C; Hornung WP; Klingmüller D; Lemke MR; Maier W; Schubert M; Sträter B; Kühn KU
    J Sex Med; 2008 Dec; 5(12):2816-26. PubMed ID: 18466271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insomnia symptoms, objectively measured sleep, and disease severity in chronic obstructive pulmonary disease outpatients.
    Hynninen MJ; Pallesen S; Hardie J; Eagan TM; Bjorvatn B; Bakke P; Nordhus IH
    Sleep Med; 2013 Dec; 14(12):1328-33. PubMed ID: 24238965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paradoxical insomnia and subjective-objective sleep discrepancy: A review.
    Rezaie L; Fobian AD; McCall WV; Khazaie H
    Sleep Med Rev; 2018 Aug; 40():196-202. PubMed ID: 29402512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained and "sleeper" effects of group metacognitive training for schizophrenia: a randomized clinical trial.
    Moritz S; Veckenstedt R; Andreou C; Bohn F; Hottenrott B; Leighton L; Köther U; Woodward TS; Treszl A; Menon M; Schneider BC; Pfueller U; Roesch-Ely D
    JAMA Psychiatry; 2014 Oct; 71(10):1103-11. PubMed ID: 25103718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sleep perception and the multiple sleep latency test in patients with primary insomnia.
    Huang L; Zhou J; Li Z; Lei F; Tang X
    J Sleep Res; 2012 Dec; 21(6):684-92. PubMed ID: 22738735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sleep disorder of schizophrenia treated with shallow needling: a randomized controlled trial].
    Huang Y; Zheng Y
    Zhongguo Zhen Jiu; 2015 Sep; 35(9):869-73. PubMed ID: 26721132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Light sleep and sleep time misperception - relationship to alpha-delta sleep.
    Martinez D; Breitenbach TC; Lenz Mdo C
    Clin Neurophysiol; 2010 May; 121(5):704-11. PubMed ID: 20153688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective, open-label study to evaluate symptomatic remission in schizophrenia with risperidone long-acting injectable in Korea.
    Lee NY; Kim SH; Cho SJ; Chung YC; Jung IK; Kim CY; Kim DH; Lee DG; Lee YH; Lim WJ; Na YS; Shin SE; Woo JM; Yoon JS; Yoon BH; Ahn YM; Kim YS
    Int Clin Psychopharmacol; 2014 Sep; 29(5):279-87. PubMed ID: 24583566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.